2015 CompetitiveWatch: Monsanto in the Global Agrochemical Industry - Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

September 2015 | 35 pages | ID: C2111CA8E39EN
Venture Planning Group

Abstracts

This strategic assessment of Monsanto, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market. SECTION I: EXECUTIVE SUMMARYA 3-5 page synopsis of key sections. SECTION II: BUSINESS ORGANIZATIONHistory of the companys agrochemical business evolution, which is important to understandingthe corporate culture, management mentality and strategies. Recent acquisitions, divestitures and major organizational changes. Current organizational structure. SECTION III: SENIOR MANAGEMENTNames, titles and background of key executives. SECTION IV: FACILITIES AND EMPLOYEESAdministrative, manufacturing and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. The U.S. and international work force size and distribution. SECTION V: TECHNOLOGICAL KNOW-HOWInternally developed and acquired agrochemical and related capabilities. Proprietary technologies and patent litigation. SECTION VI: PRODUCT PORTFOLIOReview of major product lines. Applications, advantages and weaknesses of leading products. SECTION VII: MARKETING TACTICSPromotional tactics. Distribution approaches. Product service and support. Customer relations. SECTION VIII: FINANCIAL ANALYSISEstimated sales by division, geographic region and product line. Five-year sales and operating profit performance. SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMSEstimated R&D budget. Research facilities and staff. New technologies, products and applications in development. SECTION X: COLLABORATIVE ARRANGEMENTSJoint ventures, distribution, O. E. M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. SECTION XI: STRATEGIC DIRECTIONSpecific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and divestitures. Contains 35 pages and 5 tables

Contents

MAJOR ROUTINE AND SPECIAL COAGULATION TESTS

  1. INTRODUCTION
  2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
  3. ALPHA2 ANTIPLASMIN
  4. ANTITHROMBIN III
  5. BLEEDING TIME
  6. DDIMER
  7. ETHANOL FLOCCULATION TEST
  8. EUGLOBULIN LYSIS
  9. FACTOR ASSAYS
    a. INTRODUCTION
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. FIBRIN DEGRADATION PRODUCTS
  11. FIBRINOGEN
  12. HEPARIN
  13. HIRUDIN
  14. HYPERCOAGULABILITY AND THROMBOSIS
  15. LIPOPROTEIN A
  16. PLASMIN
  17. PLASMINOGEN
  18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
  19. PLATELET FUNCTION TESTS
  20. PLATELET AGGREGATION
  21. PROTEINS C AND S
  22. PROTHROMBIN FRAGMENT 1.2
  23. PROTHROMBIN TIME (PT)
  24. REPTILASE TIME
  25. THROMBIN TIME
  26. TISSUETYPE PLASMINOGEN ACTIVATOR (TPA)
  27. VON WILLEBRAND'S FACTOR

COMPETITIVE ASSESSMENTS

Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
AxisShield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
ChronoLog
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
Hyphen BioMed
Instrumentation Laboratory
ITC/Nexus Dx
Roche
Siemens
Sienco
Sysmex
Thermo Fisher
ZyCare/Alere

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing Ddimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests